{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "a1e5bfa9-1dd1-48f3-8746-750334c84b94",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "#THE SETUP"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "cc8dc308-2509-4490-a2dc-ce15f6b4ebd3",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "# Check if the file has been uploaded"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "363783d9-9da4-47f9-8c82-a1d12045c6d1",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "execute_result",
     "data": {
      "text/plain": [
       "[FileInfo(path='dbfs:/FileStore/tables/accounts.zip', name='accounts.zip', size=5297592, modificationTime=1706707554000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/activations/', name='activations/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/activations.zip', name='activations.zip', size=8411369, modificationTime=1706707579000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinical_trial_file.csv/', name='clinical_trial_file.csv/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020', name='clinicaltrial_2020', size=46318151, modificationTime=1709585826000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-1.zip', name='clinicaltrial_2020-1.zip', size=10599182, modificationTime=1709585681000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-10.zip', name='clinicaltrial_2020-10.zip', size=10599182, modificationTime=1710096609000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-11.zip', name='clinicaltrial_2020-11.zip', size=10599182, modificationTime=1710101584000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-12.zip', name='clinicaltrial_2020-12.zip', size=10599182, modificationTime=1710227395000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-13.zip', name='clinicaltrial_2020-13.zip', size=10599182, modificationTime=1710428037000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-14.zip', name='clinicaltrial_2020-14.zip', size=10599182, modificationTime=1712925802000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-15.zip', name='clinicaltrial_2020-15.zip', size=10599182, modificationTime=1712926310000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-16.zip', name='clinicaltrial_2020-16.zip', size=10599182, modificationTime=1713215034000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-17.zip', name='clinicaltrial_2020-17.zip', size=10599182, modificationTime=1713732949000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-2.zip', name='clinicaltrial_2020-2.zip', size=10599182, modificationTime=1709586553000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-3.zip', name='clinicaltrial_2020-3.zip', size=10599182, modificationTime=1709815971000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-4.zip', name='clinicaltrial_2020-4.zip', size=10599182, modificationTime=1709967998000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-5.zip', name='clinicaltrial_2020-5.zip', size=10599182, modificationTime=1710016083000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-6.zip', name='clinicaltrial_2020-6.zip', size=10599182, modificationTime=1710019070000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-7.zip', name='clinicaltrial_2020-7.zip', size=10599182, modificationTime=1710075633000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-8.zip', name='clinicaltrial_2020-8.zip', size=10599182, modificationTime=1710080715000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-9.zip', name='clinicaltrial_2020-9.zip', size=10599182, modificationTime=1710081418000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020.csv', name='clinicaltrial_2020.csv', size=46318151, modificationTime=1710428418000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020.zip', name='clinicaltrial_2020.zip', size=10599182, modificationTime=1709555255000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-1.zip', name='clinicaltrial_2021-1.zip', size=11508457, modificationTime=1709585682000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-10.zip', name='clinicaltrial_2021-10.zip', size=11508457, modificationTime=1710096610000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-11.zip', name='clinicaltrial_2021-11.zip', size=11508457, modificationTime=1710101585000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-12.zip', name='clinicaltrial_2021-12.zip', size=13003817, modificationTime=1710227397000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-13.zip', name='clinicaltrial_2021-13.zip', size=13003817, modificationTime=1710428037000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-14.zip', name='clinicaltrial_2021-14.zip', size=11508457, modificationTime=1712925802000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-15.zip', name='clinicaltrial_2021-15.zip', size=11508457, modificationTime=1712926311000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-16.zip', name='clinicaltrial_2021-16.zip', size=11508457, modificationTime=1713215032000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-17.zip', name='clinicaltrial_2021-17.zip', size=11508457, modificationTime=1713732950000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-2.zip', name='clinicaltrial_2021-2.zip', size=11508457, modificationTime=1709586554000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-3.zip', name='clinicaltrial_2021-3.zip', size=11508457, modificationTime=1709815971000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-4.zip', name='clinicaltrial_2021-4.zip', size=11508457, modificationTime=1709967999000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-5.zip', name='clinicaltrial_2021-5.zip', size=11508457, modificationTime=1710016083000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-6.zip', name='clinicaltrial_2021-6.zip', size=11508457, modificationTime=1710019070000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-7.zip', name='clinicaltrial_2021-7.zip', size=11508457, modificationTime=1710075634000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-8.zip', name='clinicaltrial_2021-8.zip', size=11508457, modificationTime=1710080717000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-9.zip', name='clinicaltrial_2021-9.zip', size=11508457, modificationTime=1710081418000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021.csv', name='clinicaltrial_2021.csv', size=50359696, modificationTime=1710428415000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021.zip', name='clinicaltrial_2021.zip', size=11508457, modificationTime=1709555330000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023/', name='clinicaltrial_2023/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-1.zip', name='clinicaltrial_2023-1.zip', size=52785750, modificationTime=1709585695000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-10.zip', name='clinicaltrial_2023-10.zip', size=57166668, modificationTime=1710101598000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-11.zip', name='clinicaltrial_2023-11.zip', size=57166668, modificationTime=1710227423000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-12.zip', name='clinicaltrial_2023-12.zip', size=57166668, modificationTime=1710428054000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-13.zip', name='clinicaltrial_2023-13.zip', size=52785750, modificationTime=1712925826000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-14.zip', name='clinicaltrial_2023-14.zip', size=52785750, modificationTime=1712926334000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-15.zip', name='clinicaltrial_2023-15.zip', size=57166668, modificationTime=1713215039000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-16.zip', name='clinicaltrial_2023-16.zip', size=52785750, modificationTime=1713732974000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-2.zip', name='clinicaltrial_2023-2.zip', size=52785750, modificationTime=1709586566000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-3.zip', name='clinicaltrial_2023-3.zip', size=57166668, modificationTime=1709815999000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-4.zip', name='clinicaltrial_2023-4.zip', size=57166668, modificationTime=1709968018000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-5.zip', name='clinicaltrial_2023-5.zip', size=52785750, modificationTime=1710016142000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-6.zip', name='clinicaltrial_2023-6.zip', size=52785750, modificationTime=1710019103000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-7.zip', name='clinicaltrial_2023-7.zip', size=57166668, modificationTime=1710075649000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-8.zip', name='clinicaltrial_2023-8.zip', size=57166668, modificationTime=1710080734000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-9.zip', name='clinicaltrial_2023-9.zip', size=57166668, modificationTime=1710081433000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023.csv', name='clinicaltrial_2023.csv', size=292436366, modificationTime=1714210229000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023.zip', name='clinicaltrial_2023.zip', size=57166668, modificationTime=1710096624000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrials_2020.csv/', name='clinicaltrials_2020.csv/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrials_2021.csv/', name='clinicaltrials_2021.csv/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrials_2023.csv/', name='clinicaltrials_2023.csv/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/new_clinical_trial_file.csv/', name='new_clinical_trial_file.csv/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma/', name='pharma/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-1.zip', name='pharma-1.zip', size=109982, modificationTime=1709585682000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-10.zip', name='pharma-10.zip', size=109982, modificationTime=1710096604000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-11.zip', name='pharma-11.zip', size=109982, modificationTime=1710101571000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-12.zip', name='pharma-12.zip', size=109982, modificationTime=1710227397000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-13.zip', name='pharma-13.zip', size=109982, modificationTime=1710428037000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-14.zip', name='pharma-14.zip', size=109982, modificationTime=1712925689000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-15.zip', name='pharma-15.zip', size=109982, modificationTime=1713215029000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-16.zip', name='pharma-16.zip', size=109982, modificationTime=1713732951000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-2.zip', name='pharma-2.zip', size=109982, modificationTime=1709586554000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-3.zip', name='pharma-3.zip', size=109982, modificationTime=1709815961000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-4.zip', name='pharma-4.zip', size=109982, modificationTime=1709967983000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-5.zip', name='pharma-5.zip', size=109982, modificationTime=1710016088000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-6.zip', name='pharma-6.zip', size=109982, modificationTime=1710019074000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-7.zip', name='pharma-7.zip', size=109982, modificationTime=1710075620000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-8.zip', name='pharma-8.zip', size=109982, modificationTime=1710080711000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-9.zip', name='pharma-9.zip', size=109982, modificationTime=1710081414000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma.csv/', name='pharma.csv/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma.zip', name='pharma.zip', size=109982, modificationTime=1710096421000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma_file.csv/', name='pharma_file.csv/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/steam_200k-1.csv', name='steam_200k-1.csv', size=8059447, modificationTime=1710182470000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/steam_200k-2.csv', name='steam_200k-2.csv', size=8059447, modificationTime=1713183407000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/steam_200k-3.csv', name='steam_200k-3.csv', size=8059447, modificationTime=1714200223000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/steam_200k.csv', name='steam_200k.csv', size=8059447, modificationTime=1709836569000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/webpage/', name='webpage/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/webpage-1.zip', name='webpage-1.zip', size=1582, modificationTime=1707312282000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/webpage-2.zip', name='webpage-2.zip', size=1582, modificationTime=1707312555000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/webpage.zip', name='webpage.zip', size=1582, modificationTime=1707311940000)]"
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dbutils.fs.ls(\"/FileStore/tables\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "b801e5a6-6407-4a3a-ae69-ca4d9eb3b8b6",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "# Defining my variable"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "7c860526-899d-4d2f-8967-5fd5db45cb07",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [],
   "source": [
    "fileroot = \"clinicaltrial_2023\"\n",
    "pharma = \"pharma\""
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "ab114fbb-dd87-40ce-b6d1-ebc0bb6d8738",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "#Copy to the temp folder"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "4d768075-3a31-4919-aa84-ff8d2564e1ae",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "execute_result",
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dbutils.fs.cp(\"/FileStore/tables/\" + fileroot + \".zip\", \"file:/tmp/\")\n",
    "dbutils.fs.cp(\"/FileStore/tables/\" + pharma + \".zip\", \"file:/tmp/\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "1ceaf778-2f20-4df1-96ae-c22759ee0c10",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "#  Making the variable accessible by the command line"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "621946f6-bce3-4349-97b4-1ff55c45f32e",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [],
   "source": [
    "import os\n",
    "os.environ['fileroot'] = fileroot\n",
    "\n",
    "import os\n",
    "os.environ['pharma'] = pharma"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "fc4e3cad-c42a-4703-8e8a-71a5420dc82e",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "# List the contents of the temporary directory"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "ea8ac436-de72-4e8b-a818-cbeca7930553",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Rserv\nRtmpb5iDBi\nchauffeur-daemon-params\nchauffeur-daemon.pid\nchauffeur-env.sh\nclinicaltrial_2023.zip\ncustom-spark.conf\ndriver-daemon-params\ndriver-daemon.pid\ndriver-env.sh\nhsperfdata_root\npharma.zip\npython_lsp_logs\nsystemd-private-d2ffb90040804754a122110d5f59a422-systemd-logind.service-DpmX4X\nsystemd-private-d2ffb90040804754a122110d5f59a422-systemd-resolved.service-ddWvuU\ntmp.cS8ly7D2cO\n"
     ]
    }
   ],
   "source": [
    "%sh\n",
    "\n",
    "ls /tmp/"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "d0b4c577-5542-4d01-8ba4-1b5e0404f017",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "# Unzip the files"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "e0458dd2-4fd9-4760-8648-354169157ba1",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Archive:  /tmp/clinicaltrial_2023.zip\n  inflating: /tmp/clinicaltrial_2023.csv  \nArchive:  /tmp/pharma.zip\n  inflating: /tmp/pharma.csv         \n"
     ]
    }
   ],
   "source": [
    "%sh\n",
    "\n",
    "unzip -d /tmp/ /tmp/$fileroot.zip\n",
    "unzip -d /tmp/ /tmp/$pharma.zip"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "0ace7381-f389-4ccd-a0f9-969c2e8b97f8",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "# Checking the unzipped files"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "ca7597ff-edf4-43af-a8f3-b693952ce291",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/tmp/clinicaltrial_2023.csv\n/tmp/pharma.csv\n"
     ]
    }
   ],
   "source": [
    "%sh\n",
    "\n",
    "ls /tmp/$fileroot.csv\n",
    "ls /tmp/$pharma.csv"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "de0d5df1-0da7-42db-aceb-28965015b979",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "# Creating the new DBFS directory"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "c92dc5a3-d207-49c6-a85c-7c8aa4cc359a",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "execute_result",
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dbutils.fs.mkdirs(\"/FileStore/tables/\" + fileroot)\n",
    "dbutils.fs.mkdirs(\"/FileStore/tables/\" + pharma)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "56f32dd4-bdff-42d9-8e48-60ecafdd6cb1",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "# Moving the file to the new DBFS\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "778323ef-d817-4db6-8fb4-85105c20e452",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "execute_result",
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dbutils.fs.mv(\"file:/tmp/\" + fileroot + \".csv\", \"/FileStore/tables/\" + fileroot + \".csv\", True)\n",
    "dbutils.fs.mv(\"file:/tmp/\" + pharma + \".csv\", \"/FileStore/tables/\" + pharma + \".csv\", True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "f727981f-ee68-4934-a54c-8806d224cfa8",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "# Check to confirm that the files are in the directory"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "4c4cbf91-2453-4fb2-b831-f1b090ce7abd",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "execute_result",
     "data": {
      "text/plain": [
       "[FileInfo(path='dbfs:/FileStore/tables/accounts.zip', name='accounts.zip', size=5297592, modificationTime=1706707554000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/activations/', name='activations/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/activations.zip', name='activations.zip', size=8411369, modificationTime=1706707579000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinical_trial_file.csv/', name='clinical_trial_file.csv/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020', name='clinicaltrial_2020', size=46318151, modificationTime=1709585826000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-1.zip', name='clinicaltrial_2020-1.zip', size=10599182, modificationTime=1709585681000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-10.zip', name='clinicaltrial_2020-10.zip', size=10599182, modificationTime=1710096609000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-11.zip', name='clinicaltrial_2020-11.zip', size=10599182, modificationTime=1710101584000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-12.zip', name='clinicaltrial_2020-12.zip', size=10599182, modificationTime=1710227395000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-13.zip', name='clinicaltrial_2020-13.zip', size=10599182, modificationTime=1710428037000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-14.zip', name='clinicaltrial_2020-14.zip', size=10599182, modificationTime=1712925802000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-15.zip', name='clinicaltrial_2020-15.zip', size=10599182, modificationTime=1712926310000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-16.zip', name='clinicaltrial_2020-16.zip', size=10599182, modificationTime=1713215034000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-17.zip', name='clinicaltrial_2020-17.zip', size=10599182, modificationTime=1713732949000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-2.zip', name='clinicaltrial_2020-2.zip', size=10599182, modificationTime=1709586553000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-3.zip', name='clinicaltrial_2020-3.zip', size=10599182, modificationTime=1709815971000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-4.zip', name='clinicaltrial_2020-4.zip', size=10599182, modificationTime=1709967998000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-5.zip', name='clinicaltrial_2020-5.zip', size=10599182, modificationTime=1710016083000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-6.zip', name='clinicaltrial_2020-6.zip', size=10599182, modificationTime=1710019070000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-7.zip', name='clinicaltrial_2020-7.zip', size=10599182, modificationTime=1710075633000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-8.zip', name='clinicaltrial_2020-8.zip', size=10599182, modificationTime=1710080715000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020-9.zip', name='clinicaltrial_2020-9.zip', size=10599182, modificationTime=1710081418000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020.csv', name='clinicaltrial_2020.csv', size=46318151, modificationTime=1710428418000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020.zip', name='clinicaltrial_2020.zip', size=10599182, modificationTime=1709555255000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-1.zip', name='clinicaltrial_2021-1.zip', size=11508457, modificationTime=1709585682000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-10.zip', name='clinicaltrial_2021-10.zip', size=11508457, modificationTime=1710096610000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-11.zip', name='clinicaltrial_2021-11.zip', size=11508457, modificationTime=1710101585000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-12.zip', name='clinicaltrial_2021-12.zip', size=13003817, modificationTime=1710227397000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-13.zip', name='clinicaltrial_2021-13.zip', size=13003817, modificationTime=1710428037000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-14.zip', name='clinicaltrial_2021-14.zip', size=11508457, modificationTime=1712925802000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-15.zip', name='clinicaltrial_2021-15.zip', size=11508457, modificationTime=1712926311000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-16.zip', name='clinicaltrial_2021-16.zip', size=11508457, modificationTime=1713215032000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-17.zip', name='clinicaltrial_2021-17.zip', size=11508457, modificationTime=1713732950000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-2.zip', name='clinicaltrial_2021-2.zip', size=11508457, modificationTime=1709586554000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-3.zip', name='clinicaltrial_2021-3.zip', size=11508457, modificationTime=1709815971000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-4.zip', name='clinicaltrial_2021-4.zip', size=11508457, modificationTime=1709967999000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-5.zip', name='clinicaltrial_2021-5.zip', size=11508457, modificationTime=1710016083000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-6.zip', name='clinicaltrial_2021-6.zip', size=11508457, modificationTime=1710019070000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-7.zip', name='clinicaltrial_2021-7.zip', size=11508457, modificationTime=1710075634000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-8.zip', name='clinicaltrial_2021-8.zip', size=11508457, modificationTime=1710080717000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021-9.zip', name='clinicaltrial_2021-9.zip', size=11508457, modificationTime=1710081418000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021.csv', name='clinicaltrial_2021.csv', size=50359696, modificationTime=1710428415000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021.zip', name='clinicaltrial_2021.zip', size=11508457, modificationTime=1709555330000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023/', name='clinicaltrial_2023/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-1.zip', name='clinicaltrial_2023-1.zip', size=52785750, modificationTime=1709585695000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-10.zip', name='clinicaltrial_2023-10.zip', size=57166668, modificationTime=1710101598000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-11.zip', name='clinicaltrial_2023-11.zip', size=57166668, modificationTime=1710227423000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-12.zip', name='clinicaltrial_2023-12.zip', size=57166668, modificationTime=1710428054000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-13.zip', name='clinicaltrial_2023-13.zip', size=52785750, modificationTime=1712925826000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-14.zip', name='clinicaltrial_2023-14.zip', size=52785750, modificationTime=1712926334000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-15.zip', name='clinicaltrial_2023-15.zip', size=57166668, modificationTime=1713215039000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-16.zip', name='clinicaltrial_2023-16.zip', size=52785750, modificationTime=1713732974000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-2.zip', name='clinicaltrial_2023-2.zip', size=52785750, modificationTime=1709586566000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-3.zip', name='clinicaltrial_2023-3.zip', size=57166668, modificationTime=1709815999000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-4.zip', name='clinicaltrial_2023-4.zip', size=57166668, modificationTime=1709968018000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-5.zip', name='clinicaltrial_2023-5.zip', size=52785750, modificationTime=1710016142000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-6.zip', name='clinicaltrial_2023-6.zip', size=52785750, modificationTime=1710019103000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-7.zip', name='clinicaltrial_2023-7.zip', size=57166668, modificationTime=1710075649000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-8.zip', name='clinicaltrial_2023-8.zip', size=57166668, modificationTime=1710080734000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-9.zip', name='clinicaltrial_2023-9.zip', size=57166668, modificationTime=1710081433000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023.csv', name='clinicaltrial_2023.csv', size=292436366, modificationTime=1714491807000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023.zip', name='clinicaltrial_2023.zip', size=57166668, modificationTime=1710096624000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrials_2020.csv/', name='clinicaltrials_2020.csv/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrials_2021.csv/', name='clinicaltrials_2021.csv/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/clinicaltrials_2023.csv/', name='clinicaltrials_2023.csv/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/new_clinical_trial_file.csv/', name='new_clinical_trial_file.csv/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma/', name='pharma/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-1.zip', name='pharma-1.zip', size=109982, modificationTime=1709585682000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-10.zip', name='pharma-10.zip', size=109982, modificationTime=1710096604000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-11.zip', name='pharma-11.zip', size=109982, modificationTime=1710101571000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-12.zip', name='pharma-12.zip', size=109982, modificationTime=1710227397000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-13.zip', name='pharma-13.zip', size=109982, modificationTime=1710428037000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-14.zip', name='pharma-14.zip', size=109982, modificationTime=1712925689000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-15.zip', name='pharma-15.zip', size=109982, modificationTime=1713215029000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-16.zip', name='pharma-16.zip', size=109982, modificationTime=1713732951000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-2.zip', name='pharma-2.zip', size=109982, modificationTime=1709586554000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-3.zip', name='pharma-3.zip', size=109982, modificationTime=1709815961000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-4.zip', name='pharma-4.zip', size=109982, modificationTime=1709967983000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-5.zip', name='pharma-5.zip', size=109982, modificationTime=1710016088000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-6.zip', name='pharma-6.zip', size=109982, modificationTime=1710019074000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-7.zip', name='pharma-7.zip', size=109982, modificationTime=1710075620000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-8.zip', name='pharma-8.zip', size=109982, modificationTime=1710080711000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma-9.zip', name='pharma-9.zip', size=109982, modificationTime=1710081414000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma.csv/', name='pharma.csv/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma.zip', name='pharma.zip', size=109982, modificationTime=1710096421000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/pharma_file.csv/', name='pharma_file.csv/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/steam_200k-1.csv', name='steam_200k-1.csv', size=8059447, modificationTime=1710182470000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/steam_200k-2.csv', name='steam_200k-2.csv', size=8059447, modificationTime=1713183407000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/steam_200k-3.csv', name='steam_200k-3.csv', size=8059447, modificationTime=1714200223000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/steam_200k.csv', name='steam_200k.csv', size=8059447, modificationTime=1709836569000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/webpage/', name='webpage/', size=0, modificationTime=0),\n",
       " FileInfo(path='dbfs:/FileStore/tables/webpage-1.zip', name='webpage-1.zip', size=1582, modificationTime=1707312282000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/webpage-2.zip', name='webpage-2.zip', size=1582, modificationTime=1707312555000),\n",
       " FileInfo(path='dbfs:/FileStore/tables/webpage.zip', name='webpage.zip', size=1582, modificationTime=1707311940000)]"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dbutils.fs.ls(\"/FileStore/tables/\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "a213f9d7-9739-40f3-b0d4-1151d223ed5d",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "# View the content of our clinical trial dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "05b849aa-2177-4dda-a93d-210a4f264336",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Truncated to first 65536 bytes]\n"
     ]
    },
    {
     "output_type": "execute_result",
     "data": {
      "text/plain": [
       "'\"Id\\tStudy Title\\tAcronym\\tStatus\\tConditions\\tInterventions\\tSponsor\\tCollaborators\\tEnrollment\\tFunder Type\\tType\\tStudy Design\\tStart\\tCompletion\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03630471\\tEffectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India\\tPRIDE\\tCOMPLETED\\tMental Health Issue (E.G.\", Depression, Psychosis, Personality Disorder,\" Substance Abuse)\\tBEHAVIORAL: PRIDE \\'Step 1\\' problem-solving intervention|BEHAVIORAL: Enhanced usual care\\tSangath\\tHarvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine\\t250.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR\",\" OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2018-08-20\\t2019-02-28\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05992571\\tOral Ketone Monoester Supplementation and Resting-state Brain Connectivity\\t\\tRECRUITING\\tCerebrovascular Function|Cognition\\tOTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB\\tMcMaster University\\tAlzheimer\\'s Society of Brant\", Haldimand Norfolk,\" Hamilton Halton\\t30.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT\", INVESTIGATOR,\" OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE\\t2023-10-25\\t2024-08\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00237471\\tImpact of Tight Glycaemic Control in Acute Myocardial Infarction\\t\\tTERMINATED\\tMyocardial Infarct|Hyperglycemia\\tDRUG: Insulin (tight blood glucose control)\\tMelbourne Health\\tNational Health and Medical Research Council\",\" Australia|Bristol-Myers Squibb\\t40.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\\t2005-10\\t2006-05\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03820271\\tNew Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation\\tSUPERMELD\\tRECRUITING\\tDecompensated Cirrhosis|Liver Transplantation\\tOTHER: SuperMELD\\tAssistance Publique - Hôpitaux de Paris\\t\\t500.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\\t2020-10-01\\t2023-10-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT06229171\\tInTake Care: Development and Validation of an Innovative\",\" Personalized Digital Health Solution for Medication Adherence Support in Cardiovascular Prevention\\tInTakeCare\\tNOT_YET_RECRUITING\\tHypertension|Treatment Adherence and Compliance|Digital Health\\tOTHER: adherence support system based on a vocal assistant\\tIstituto Auxologico Italiano\\tIstituti Clinici Scientifici Maugeri SpA|Politecnico di Milano\\t206.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER\\t2024-10-01\\t2026-04-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02945371\\tTailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life\\tREV\\tCOMPLETED\\tSmoking|Alcohol Drinking|Prescription Drug Abuse|Substance-Related Disorders|Oral Intake Reduced\\tBEHAVIORAL: Person-centered inhibitory control training|BEHAVIORAL: Active behavioral response training\\tUniversity of Oregon\\t\\t103.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION\\t2014-09\\t2016-05\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01055171\\tNeuromodulation of Trauma Memories in PTSD & Alcohol Dependence\\t\\tCOMPLETED\\tAlcohol Dependence|PTSD\\tDRUG: Propranolol|DRUG: Placebo\\tMedical University of South Carolina\\tNational Institute on Alcohol Abuse and Alcoholism (NIAAA)\\t44.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT\", CARE_PROVIDER, INVESTIGATOR,\" OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2010-01\\t2012-08\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01125371\\tComputerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women\\t\\tCOMPLETED\\tAlcohol; Harmful Use|Binge Drinking|Risk Behavior|HIV Infection\\tBEHAVIORAL: Computerized brief alcohol intervention + IVR booster calls|BEHAVIORAL: Computerized brief alcohol intervention|BEHAVIORAL: Attention Control\\tJohns Hopkins University\\tNational Institute on Alcohol Abuse and Alcoholism (NIAAA)\\t439.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR\",\" OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2011-10\\t2016-06-07\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02554071\\tManitoba Pharmacist Initiated Smoking Cessation Pilot Project\\t\\tCOMPLETED\\tSmoking Cessation\\tOTHER: Pharmacist - Smoking Cessation Support\\tUniversity of Manitoba\\tGovenment of Manitoba|Canadian Foundation for Pharmacy|Neighbourhood Pharmacy Association of Canada\\t119.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\\t2014-01\\t2014-11\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01772771\\tMolecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program\\t\\tRECRUITING\\tGlioma|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Melanoma|Sarcoma\\tPROCEDURE: Biospecimen Collection|OTHER: Genetic Testing|OTHER: Medical Chart Review\\tM.D. Anderson Cancer Center\\tNational Cancer Institute (NCI)\\t12000.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2012-03-01\\t2033-03-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02633371\\tA Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults\\t\\tCOMPLETED\\tHyperhidrosis\\tDRUG: Oxybutynin 3% gel\\tUniversity of Colorado\",\" Denver\\tSociety for Pediatric Dermatology\\t10.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\\t2016-02\\t2017-05\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03400371\\tBiology of Juvenile Myoclonic Epilepsy\\tBIOJUME\\tRECRUITING\\tJuvenile Myoclonic Epilepsy\\tOTHER: Blood draw|OTHER: Existing samples\\tKing\\'s College London\\tKing\\'s College Hospital NHS Trust|Charles University\",\" Czech Republic|Hopital Universitaire Robert-Debre|Vestre Viken Hospital Trust|The Hospital for Sick Children|Cardiff University|Odense University Hospital\\t1000.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2017-07-13\\t2026-06-30\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00120471\\tSafety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies\\t\\tCOMPLETED\\tHIV Infections\\tDRUG: Tenofovir disoproxil fumarate|DRUG: Tenofovir disoproxil fumarate|DRUG: Tenofovir disoproxil fumarate\\tNational Institute of Allergy and Infectious Diseases (NIAID)\\tEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|National Institute on Drug Abuse (NIDA)|National Institute of Mental Health (NIMH)\\t122.0\\tNIH\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\\t2006-11\\t2011-12\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04784871\\tPromoting Wellbeing: The Five Ways to All Intervention\\t5WaysA\\tCOMPLETED\\tWellbeing|Health Attitude|Quality of Life\\tBEHAVIORAL: 5waysA Intervention|BEHAVIORAL: 5waysA Active wait-list control|BEHAVIORAL: 5waysA Inactive wait-list control\\tUniversity of Oslo\\tNorwegian Institute of Public Health|Norwegian Council for Mental Health|The Dam Foundation\\t970.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\\t2021-03-04\\t2023-02-24\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02383771\\tReversal of the Anti-platelet Effects of Ticagrelor\\tREVERSAL\\tCOMPLETED\\tCoronary Artery Disease\\tDRUG: Ticagrelor|DRUG: Aspirin + Ticagrelor|DRUG: Control|DRUG: Aspirin + Ticagrelor\\tThe First Affiliated Hospital with Nanjing Medical University\\tNational Natural Science Foundation of China\\t64.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT\\t2015-03\\t2016-12\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03269071\\tNeural Stem Cell Transplantation in Multiple Sclerosis Patients\\tSTEMS\\tCOMPLETED\\tProgressive Multiple Sclerosis\\tDRUG: human fetal-derived Neural Stem Cells (hNSCs)\\tIRCCS San Raffaele\\tFondazione Italiana Sclerosi Multipla\\t4.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT\\t2017-05-17\\t2021-07-31\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01659671\\tRCT of the Effect of Uvulopalatopharyngoplasty Compared to Expectancy in Patients With Obstructive Sleep Apnea\\tSKUP3\\tCOMPLETED\\tObstructive Sleep Apnea Syndrome\\tPROCEDURE: Uvulopalatopharyngoplasty\\tKarolinska University Hospital\\tKarolinska Institutet\\t65.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2007-06\\t2014-05\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04765371\\tComparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy\",\" With CoViD-19\\tCOPreDex\\tCOMPLETED\\tCoronavirus Infection\\tDRUG: DEXAMETHASONE|DRUG: PREDNISOLONE\\tHôpital NOVO\\t\\t89.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\\t2021-03-03\\t2022-05-13\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02830971\\tDeveloping a Standardized Learning Curve\\t\\tCOMPLETED\\tRegistered Nurses|Nursing Personnel|Motor Skills\\tPROCEDURE: Doing Different ICU techniques and skills\\tBaqiyatallah Medical Sciences University\\tShahid Beheshti University|Tehran University of Medical Sciences\\t60.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE\\t2016-07\\t2021-04-12\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00416871\\tInterleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer\\t\\tCOMPLETED\\tKidney Cancer\\tBIOLOGICAL: aldesleukin|BIOLOGICAL: recombinant interferon alfa\\tCentre Leon Berard\\t\\t220.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT\\t\\t2006-02\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05900271\\tDutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst Sessions With 6 Weeks rTMS\\tDDOT\\tACTIVE_NOT_RECRUITING\\tTreatment Resistant Depression\\tDEVICE: rTMS|DEVICE: iTBS\\tAmsterdam UMC\",\" location VUmc\\tRadboud University Medical Center|University Medical Center Groningen|Maastricht University|Trimbos|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)\\t108.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2023-11-15\\t2027-12\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02469571\\tModulation of Gut Microbiota in Early Sepsis: A Pilot Study\\tMGM-sepsis\\tCOMPLETED\\tSepsis\\tDIETARY_SUPPLEMENT: Winclove 607|DIETARY_SUPPLEMENT: Placebo\\tMedical University of Graz\\t\\t15.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT\", CARE_PROVIDER, INVESTIGATOR,\" OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\\t2015-09-01\\t2018-03-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05807971\\tAssessment of Safety\", Tolerability, Pharmacokinetics,\" and Pharmacodynamics of ATH-063 in Healthy Subjects\\t\\tRECRUITING\\tInflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis|Autoimmune Diseases\\tDRUG: ATH-063|DRUG: Placebo\\tAthos Therapeutics Inc\\tSyneos Health|Athos Therapeutics Australia Pty Ltd\\t76.0\\tINDUSTRY\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT\", CARE_PROVIDER, INVESTIGATOR,\" OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2023-04-06\\t2024-02-08\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02083471\\tCow\\'s Milk and Hen\\'s Egg Hyposensitization in Adults\\t\\tUNKNOWN\\tEgg Allergy|Cow\\'s Milk Allergy\\tDIETARY_SUPPLEMENT: Specific Oral Tolerance Induction with Egg or Cow\\'s milk\\tTurku University Hospital\\t\\t40.0\\tOTHER_GOV\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\\t2015-04\\t2017-05\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01062971\\tClinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide\\t\\tCOMPLETED\\tPrimary Open Angle Glaucoma|Ocular Hypertension\\tDRUG: dorzolamide-timolol-brimonidine\\tLaboratorios Sophia S.A de C.V.\\t\\t124.0\\tINDUSTRY\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT\",\" INVESTIGATOR)|Primary Purpose: TREATMENT\\t2006-02\\t2008-06\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03928171\\tThe Effect of Intra-abdominal Pressure on Peritoneal Perfusion During Laparoscopic Colorectal Surgery\\tPERFUSION\\tCOMPLETED\\tLaparoscopic Surgery|Pneumoperitoneum\\tOTHER: Intra-abdominal pressure during laparoscopy\\tRadboud University Medical Center\\t\\t30.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT\", CARE_PROVIDER,\" OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2018-06-13\\t2018-12-24\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00897871\\tEvaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer\\t\\tUNKNOWN\\tUnspecified Childhood Solid Tumor\",\" Protocol Specific\\tDRUG: carboplatin|DRUG: cyclophosphamide|DRUG: etoposide phosphate|GENETIC: gene expression analysis|GENETIC: polymorphism analysis|OTHER: pharmacological study\\tChildren\\'s Cancer and Leukaemia Group\\t\\t60.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2007-02\\t\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00848471\\tValidation of the Quark RMR Calorimeter (Cosmed) Versus Deltatrac II (GE Health Care Clinical Systems)\\tProtocol Quark\\tUNKNOWN\\tHealthy|Obesity\\tDEVICE: Quark RMR|DEVICE: Deltatrac II\\tHospices Civils de Lyon\\tCentre de Recherche en Nutrition Humaine Rhone-Alpe\\t30.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH\\t2009-01\\t2009-12\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT06135571\\tStudy on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer\\t\\tRECRUITING\\tColorectal Cancer|Lymph Node Metastasis\\tPROCEDURE: Laparoscopic colorectal surgery\\tCancer Institute and Hospital\",\" Chinese Academy of Medical Sciences\\tPeking Union Medical College Hospital|Peking University Cancer Hospital & Institute|China-Japan Friendship Hospital|Chinese PLA General Hospital\\t3000.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2023-09-01\\t2026-09-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01189071\\tPreoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain\\t\\tTERMINATED\\tOveractive Bladder|Renal Colic|Pain\",\" Postoperative\\tDRUG: Darifenacin\\tUniversity of Missouri-Columbia\\t\\t3.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT\",\" INVESTIGATOR)|Primary Purpose: TREATMENT\\t2009-08\\t2011-07\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00728871\\tThe Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their Prognosis\\t\\tUNKNOWN\\tCervical Cancer|Cervical Intraepithelial Neoplasia\\tPROCEDURE: peripheral blood isolation\\tNational Taiwan University Hospital\\t\\t600.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE\\t2005-12\\t2011-12\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05592171\\tOcclusafe® Assisted MW Alone or With DEB-TACE Compared to MW With DEB-TACE in the Treatment of HCC\\tSEASON-HCC\\tRECRUITING\\tHCC\\tPROCEDURE: Microwave ablation + Occlusafe + DEB-TACE|PROCEDURE: Microwave ablation + Occlusafe|PROCEDURE: Microwave ablation + DEB-TACE\\tUniversity of Pisa\\tAzienda Ospedaliera Città della Salute e della Scienza di Torino|Fondazione Policlinico Universitario Agostino Gemelli IRCCS|Azienda Ospedaliera Universitaria Policlinico|IRCCS Azienda Ospedaliero-Universitaria di Bologna|Terumo Europe N.V.|Azienda Ospedaliero\",\" Universitaria Pisana\\t60.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\\t2022-10-17\\t2025-10-17\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00520871\\tThe Water-Blueberry Study\\t\\tCOMPLETED\\tCardiovascular Disease\\tDRUG: Blueberry juice\\tUniversity of Oslo\\tUllevaal University Hospital\\t62.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: PREVENTION\\t2003-03\\t2004-04\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05913271\\tStudy on the Correlation Between NAT2(N-acetyltransferase2) Gene Polymorphism and CrCl(Creatine Clreance) and the Efficacy and Safety of Levosimendan in Patients With Severe Heart Failure\\t\\tRECRUITING\\tHeart Failure|Levosimendan|Efficacy|Safety\\t\\tYi Han\\tQianfoshan Hospital\\t352.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2023-05-30\\t2025-05-30\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04006171\\tComparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women\\tCNP\\tCOMPLETED\\tPolycystic Ovary Syndrome|c Type Natriuretic Peptide|Menstrual Irregularity|Hyperandrogenism\\tDIAGNOSTIC_TEST: C type natriuretic peptide\\tNear East University\",\" Turkey\\t\\t90.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC\\t2019-07-15\\t2020-09-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04370171\\tManagement of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic\\tTeleCoviDiab\\tCOMPLETED\\tDiabetes|Covid-19\\tOTHER: care modalities|OTHER: Teleconsultation either by phone or by computer consultation\\tUniversity Hospital\", Strasbourg,\" France\\t\\t610.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2020-05-04\\t2020-05-29\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04340271\\tThe Clinical Utility of Extracorporeal Shock Wave Therapy on Burns\\t\\tCOMPLETED\\tBurn Scar\\tOTHER: Extracorporeal shock wave therapy|OTHER: conventional occupational therapy\\tHangang Sacred Heart Hospital\\t\\t48.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT\",\" OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2020-04-15\\t2020-05-31\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03075371\\tHomeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa\\t\\tCOMPLETED\\tAnorexia Nervosa|Healthy\\tOTHER: Glucose|OTHER: Placebo\\tUniversity of Heidelberg Medical Center\\tGerman Research Foundation\\t85.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE\\t2014-09\\t2019-02\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05966571\\tOvarian Innervation Study in Patients With Polycystic Ovary Syndrome (PCOS)\\t\\tRECRUITING\\tPolycystic Ovary Syndrome\\tPROCEDURE: Ovary Biopsie\\tAlbanian University\\t\\t50.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2023-07-01\\t2024-12-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03313271\\tChina Lymphoma Patient Registry Study\\tCLAP\\tRECRUITING\\tLymphoma\\t\\tJun Zhu\\tPeking University First Hospital|Tianjin Medical University Cancer Hospital|Zhejiang Cancer Hospital|Heilongjiang Cancer Hospital|Sipai(Beijing)Network Technology Co Ltd\\t5000.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2017-05-17\\t2027-08-30\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03490071\\tLong-term Follow up of Patients With Longstanding Hip and Groin Pain\\tLund LHGP\\tRECRUITING\\tHip Pain Chronic\\t\\tLund University\\t\\t81.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2018-01-01\\t2024-12-31\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05801471\\tClinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression\\t\\tRECRUITING\\tGlaucoma\\t\\tCentervue SpA\\t\\t200.0\\tINDUSTRY\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2022-05-06\\t2025-11-06\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00266071\\tStudy of the Cutaneous Microcirculation in Elderly People\\t\\tUNKNOWN\\tElderly People\\tBEHAVIORAL: Cutaneous response\\tUniversity Hospital\",\" Angers\\t\\t\\tOTHER_GOV\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2005-12\\t\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04405271\\tTAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)\\t\\tUNKNOWN\\tHealthcare Workers|COVID-19|SARS-CoV 2\\tDRUG: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|DRUG: Placebo\\tHospital Italiano de Buenos Aires\\tSociedad Argentina de Infectología (SADI) (Argentine Society of Infectious Diseases)\\t1378.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT\", CARE_PROVIDER, INVESTIGATOR,\" OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\\t2020-07-31\\t2020-11-15\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02121171\\tCombined Trab+Trab Versus Combined Trab+Trab With Subconjunctival Implantation of Ologen for Primary Congenital Glaucoma\\t\\tUNKNOWN\\tCongenital Glaucoma\\tDEVICE: Ologen Collagen Matrix|PROCEDURE: Combined trabeculotomy-trabeculectomy\\tNational Centre of Ophthalmology named after academician Zarifa Aliyeva\\tAeon Astron Europe B.V.\\t40.0\\tOTHER_GOV\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\\t2010-09\\t2015-09\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01068171\\tDeveloping a Diabetic Foot Ulcer Protocol\\t\\tWITHDRAWN\\tDiabetic Foot Ulcers\\tOTHER: type of footwear|OTHER: collagen dressing with and without silver\\tThe University of Texas Health Science Center\",\" Houston\\tHarris County Hospital District|Baylor College of Medicine\\t0.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\\t2010-05\\t2012-06\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04875871\\tParticle-based Partial Tumor Irradiation of Unresectable Bulky Tumors\\tPARTICLE-PATHY\\tRECRUITING\\tCancer\\tRADIATION: Particle radiotherapy|DIAGNOSTIC_TEST: Magnetic resonance imaging|DIAGNOSTIC_TEST: Computertomography|DIAGNOSTIC_TEST: Copper-64-Diacetyl-bis (N4-methylthiosemicarbazone) Positron Emission Tomography-Computer Tomography (64Cu-ATSM-PET-CT)|DIAGNOSTIC_TEST: 18-F-FluorDesoxyGlukose Positron Emission Tomography-Computer Tomography (18F-FDG-PET-CT)|DIAGNOSTIC_TEST: Blood sampling\\tEBG MedAustron GmbH\\tCW-Research & Management GmbH|Medical University of Vienna|Landesklinkum Wiener Neustadt|Klinik Ottakring\\t22.0\\tINDUSTRY\\tINTERVENTIONAL\\tAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\\t2021-11-11\\t2024-12\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00553371\\tFollow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer\\t\\tUNKNOWN\\tTesticular Germ Cell Tumor\\tOTHER: biomarker analysis|PROCEDURE: computed tomography\\tRoyal Marsden NHS Foundation Trust\\t\\t300.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2006-04\\t\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04674371\\tGerman Point Prevalence Study on CVC\\t\\tCOMPLETED\\tData Collection\\tOTHER: central venous catheter insertion\\tWolfram Schummer\", MD,\" PhD\\t\\t537.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2022-05-17\\t2022-05-20\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02321371\\tEffect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.\\t\\tCOMPLETED\\tAcute-On-Chronic Liver Failure\\tDRUG: Lactulose + Rifaximin|DRUG: Lactulose\\tInstitute of Liver and Biliary Sciences\",\" India\\t\\t73.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\\t2014-10-19\\t2016-01-31\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02344771\\tPerioperative Endothelial Dysfunction\\t\\tCOMPLETED\\tMyocardial Injury\\tPROCEDURE: Elective colon cancer surgery\\tZealand University Hospital\\t\\t31.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2015-03\\t2015-06\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03354871\\tDeveloping Models for Fatigue Monitoring in Obstetrics and Gyne- Cology Residents Using Wearables\\tIoT4Resident\\tUNKNOWN\\tFatigue\\t\\tHillel Yaffe Medical Center\\tInternational Business Machines (IBM)\\t6.0\\tOTHER_GOV\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2017-11\\t2018-02-28\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02804971\\tCardiovascular Comorbidities and Bronchiectasis\\tBRONCOCA\\tACTIVE_NOT_RECRUITING\\tBronchiectasis\\t\\tCentre Hospitalier Intercommunal Creteil\\t\\t200.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2016-10-25\\t2023-12\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04591171\\tAssessing the Feasibility of N-of-1 Trials in Children With Hypertension and Chronic Kidney Disease\\t\\tCOMPLETED\\tHypertension|Chronic Kidney Diseases\\tPROCEDURE: n-of-1 trial guided clinical decision making\\tThe University of Texas Health Science Center\",\" Houston\\tChildren\\'s Hospital of Philadelphia|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\\t9.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\\t2021-01-25\\t2022-02-18\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04814771\\tMass Balance Study of TS-142 in Healthy Adult Subjects.\\t\\tCOMPLETED\\tHealthy Male Subjects\\tDRUG: [14C] TS-142\\tTaisho Pharmaceutical Co.\",\" Ltd.\\t\\t6.0\\tINDUSTRY\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE\\t2021-04-19\\t2021-05-19\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00991471\\tThe Effect of an Physician-Nurse Supplementary Triage Assistance Team on Emergency Department Patient Wait Times\\tMDRNSTAT\\tCOMPLETED\\tEmergencies\\tBEHAVIORAL: Interaction with MDRN STAT|BEHAVIORAL: No MDRNSTAT\\tSunnybrook Health Sciences Centre\\t\\t6300.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH\\t2009-09\\t2010-02\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05702671\\tKenota 1 CWS Method Comparison Validation Study\\t\\tCOMPLETED\\tAllergy|Immunoglobulin E-Mediated Allergic Disorder\\tDIAGNOSTIC_TEST: Total Immunoglobulin E\",\" Obtained From Fingerstick Sample\\tKenota Inc.\\t\\t411.0\\tINDUSTRY\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2023-01-27\\t2023-04-07\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02069171\\tCross-sectional and Questionnaire Study for Leg Lymphedema\\t\\tCOMPLETED\\tGynecologic Cancer\\t\\tNational Cancer Center\",\" Korea\\t\\t333.0\\tOTHER_GOV\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2012-06\\t2012-11\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00474071\\tOptimum Dose of Remifentanil for Intubation in Small Children\\t\\tCOMPLETED\\tEndotracheal Intubation\\tDRUG: Remifentanil\\tUniversity of British Columbia\\t\\t60.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT\",\" INVESTIGATOR)|Primary Purpose: TREATMENT\\t2007-03\\t2008-04\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02022371\\tProstate Cancer Genomic Heterogeneity\\tPROGENY\\tCOMPLETED\\tPROSTATE CANCER\\tPROCEDURE: Targeted biopsies of the prostate\\tUniversity College London Hospitals\\t\\t50.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC\\t2014-09\\t2016-06\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04585971\\tA Study on Hemodynamic Relationship Including Cerebral Blood Flow Using Phase Contrast and Signal Intensity Gradient of Brain Magnetic Resonance Imaging\",\" and Carotid Doppler Ultrasound\\t\\tUNKNOWN\\tCerebral Blood Flow\\tDIAGNOSTIC_TEST: Signal intensity gradient\\tChonbuk National University Hospital\\tMedi Image\",\" Inc\\t30.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2020-09-03\\t2021-01-31\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05473871\\tEnhancing Capacity in Churches to Implement PA Programs\\t\\tRECRUITING\\tCardiovascular Diseases\\tBEHAVIORAL: Faith in Action|BEHAVIORAL: Faith in Action+|BEHAVIORAL: Faith in Action++\\tSan Diego State University\\tWashington University School of Medicine|University of California\", Berkeley|University of California,\" San Diego\\t812.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT\", INVESTIGATOR,\" OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\\t2022-11-15\\t2026-10-31\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01523171\\tPhase II\", Open Label,\" Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib\\tJAKARTA2\\tCOMPLETED\\tHematopoietic Neoplasm\\tDRUG: SAR302503\\tSanofi\\t\\t97.0\\tINDUSTRY\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\\t2012-04\\t2014-04\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00000571\\tTrial of Inspiratory Muscle Rest and Exercise in Chronic Obstructive Lung Disease\\t\\tCOMPLETED\\tLung Diseases|Lung Diseases\",\" Obstructive|Chronic Obstructive Pulmonary Disease\\tDEVICE: ventilators\",\" negative pressure\\tMcGill University\\tNational Heart\", Lung,\" and Blood Institute (NHLBI)\\t\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT\\t1986-02\\t\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01053871\\tPropofol Versus Midazolam With Fentanyl for EGD Endomicroscopy\\t\\tCOMPLETED\\tGastritis|Functional Dyspepsia\\tDRUG: propofol|DRUG: midazolam with fentanyl\\tShandong University\\t\\t104.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT\",\" INVESTIGATOR)|Primary Purpose: \\t2010-01\\t2010-05\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02370771\\tProteomic Analysis in Sera From Patients With Erosive Hand Osteoarthritis\\tPASEO\\tCOMPLETED\\tErosive Hand Osteoarthritis\\tPROCEDURE: Biological sampling|DEVICE: Radiographic evaluation\\tUniversity Hospital\",\" Rouen\\t\\t32.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC\\t2015-06-09\\t2019-11-17\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05974371\\tEpisodic Memory Integration and Interference\\t\\tNOT_YET_RECRUITING\\tEpisodic Memory\\tOTHER: emotional context similarity\\tBoston College\\t\\t150.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE\\t2024-08\\t2027-08\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03713671\\tGait and Balance Parameters Before and After Parathyroidectomy in Patients With Primary Hyperparathyroidism\\t\\tCOMPLETED\\tPrimary Hyperparathyroidism\\tDIAGNOSTIC_TEST: gait analysis\\tRecep Tayyip Erdogan University Training and Research Hospital\\tHacettepe University|Ankara Education and Research Hospital\\t40.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SCREENING\\t2021-10-17\\t2023-08-27\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02645071\\tBrief Program in Reducing Sedentary Behavior and Promoting Physical Exercise\\t\\tCOMPLETED\\tPhysical Activity\\tBEHAVIORAL: Physical Activity\\tThe University of Hong Kong\\tHong Kong Jockey Club Charities Trust\\t141.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION\\t2015-07\\t2017-07\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04004871\\tInduction Chemotherapy With Nab-paclitaxel\",\" Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma\\t\\tUNKNOWN\\tNasopharyngeal Carcinoma|Nasopharyngeal Cancer|Nasopharynx Cancer\\tDRUG: Nab-paclitaxel\",\" Cisplatin and Fluorouracil|RADIATION: concurrent chemoradiotherapy\\tGuangxi Medical University\\tSecond Affiliated Hospital of Guangxi Medical University|Guilin Medical University\",\" China|Liuzhou Workers Hospital|Wuzhou Red Cross Hospital\\t60.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\\t2019-07-05\\t2022-06-30\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05953571\\tLaparoscopic Assisted Dismembered Pyeloplasty Versus Open Pyeloplasty in (UPJO) With Poorly Function Kidney in Pediatrics\\t\\tCOMPLETED\\tUretro-pelvic Junction Obstruction|Poorly Function Kidney\\tPROCEDURE: Dismembered Pyeloplasty\\tAl-Azhar University\\tUniversity Hospital Fattouma Bourguiba\\t65.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2022-01-08\\t2023-06-30\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02570971\\tMannitol Versus Supportive Care in Ciguatera Fish Poisoning\\t\\tUNKNOWN\\tCiguatoxin\\tDRUG: Mannitol\\tUniversity of South Florida\\tFlorida Poison Control Center\\t200.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT\", CARE_PROVIDER,\" INVESTIGATOR)|Primary Purpose: TREATMENT\\t2015-10\\t\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03987971\\tAcupuncture on GB26 to Treat Chronic Low Back Pain\\t\\tUNKNOWN\\tChronic Low-back Pain\\tOTHER: acupuncture\\tWenzhou Medical University\\tQingtian People\\'s hospital\\t114.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT\", INVESTIGATOR,\" OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2020-01\\t2021-07\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01425671\\tNeural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States\\t\\tACTIVE_NOT_RECRUITING\\tSchizophrenia|Schizoaffective Disorder|Schizophreniform Disorder\\t\\tUniversity of Maryland\",\" Baltimore\\tNational Institute of Mental Health (NIMH)\\t800.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2010-11-30\\t2024-06\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04962971\\tComparative Effect of 3 Different Cranberry Extracts on Cystitis Related Urinary Comfort in Women\\t\\tCOMPLETED\\tRecurrent Cystitis\\tDIETARY_SUPPLEMENT: X|DIETARY_SUPPLEMENT: Y|DIETARY_SUPPLEMENT: Z\\tCEN Biotech\\tNexira|CEN Nutriment\\t216.0\\tINDUSTRY\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2020-09-01\\t2022-02-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02827071\\tOcular Imaging Study Using Advanced OCT\\t\\tUNKNOWN\\tRetinal Vascular Disorder|Macular Degeneration\\t\\tUniversity of California\",\" Los Angeles\\t\\t1000.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2016-07\\t\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04236271\\tTELEsurveillance of Patients in PostopErative Bridge surgeryAge CoronairE\\tTELE-PEACE\\tCOMPLETED\\tCoronary Artery Bypass\\tDEVICE: connected objects\\tAssistance Publique - Hôpitaux de Paris\\tGFI\\t33.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\\t2020-03-13\\t2022-12-31\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01780571\\tCPAP/PSV Preoxygenation in Obese Patients\\t\\tCOMPLETED\\tObesity|Anaesthesia\\tPROCEDURE: CPAP 5 cm H2O + PSV 5 cm H2O\\tKarolinska Institutet\\t\\t44.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION\\t2009-05\\t2012-12\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05078671\\tPharmacokinetic Boosting of Olaparib to Improve Exposure\",\" Tolerance and Cost-effectiveness\\tPROACTIVE\\tRECRUITING\\tCancer\\tDRUG: Olaparib|DRUG: Cobicistat\\tRadboud University Medical Center\\t\\t160.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\\t2021-12-15\\t2025-12-31\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02529371\\tPre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients\\t\\tUNKNOWN\\tUrinary Incontinence\\tDEVICE: UriCap-RM\\tG.R. Dome Medical Ltd.\\t\\t30.0\\tINDUSTRY\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\\t2015-09\\t2015-10\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02309671\\tA Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment\\t\\tCOMPLETED\\tInfertility\\tDRUG: FE 999049|DRUG: follitropin beta\\tFerring Pharmaceuticals\\t\\t159.0\\tINDUSTRY\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2014-12\\t2016-09\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03876171\\tCulturally Modified Family Based Therapy for Haitian Youth in South Florida\\t\\tCOMPLETED\\tProblem Behavior\\tBEHAVIORAL: Haitian youth and family intervention study: family functioning|BEHAVIORAL: Haitian youth intervention study: youth psychoeducational|BEHAVIORAL: Haitian family intervention study: family psychoeducational|BEHAVIORAL: Diversion Programs\\tUniversity of Miami\\tNational Institute on Drug Abuse (NIDA)\\t44.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\\t2019-04-01\\t2022-12-31\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05031871\\tPharmacokinetics of HR17031 Injection in Healthy Subjects\\t\\tCOMPLETED\\tType 2 Diabetes Mellitus\\tDRUG: HR17031 injection ；INS068 injection；SHR20004 injection|DRUG: HR17031 injection ；INS068 injection；SHR20004 injection|DRUG: HR17031 injection ；INS068 injection；SHR20004 injection|DRUG: HR17031 injection ；INS068 injection；SHR20004 injection\\tJiangsu HengRui Medicine Co.\",\" Ltd.\\t\\t24.0\\tINDUSTRY\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT\\t2021-09-02\\t2021-11-19\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04769271\\tIntra-pocket Application of Tea Tree Oil Gel in the Treatment of Stage-2 Periodontitis\\t\\tCOMPLETED\\tPeriodontitis\\tPROCEDURE: Scaling and Root Planing|DRUG: Scaling and Root Planing with tea tree oil\\tAlexandria University\\t\\t30.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2019-11-10\\t2020-08-25\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT06044571\\tOptimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults\\t\\tNOT_YET_RECRUITING\\tObesity|Multiple Chronic Conditions\\tOTHER: Prescriptive|BEHAVIORAL: Behavioral\\tUniversity of North Carolina\",\" Chapel Hill\\tNational Institute on Aging (NIA)\\t180.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: DOUBLE (PARTICIPANT\",\" CARE_PROVIDER)|Primary Purpose: TREATMENT\\t2024-03-01\\t2027-09-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01889771\\tA Cost-effectiveness Study of Nicotine Patches Distributed Through a Quitline\\t\\tCOMPLETED\\tSmoking Cessation\\tDRUG: Nicotine Patch\\tUniversity of Colorado\",\" Denver\\t\\t1495.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH\\t2010-03\\t2012-03\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03077971\\tEffectiveness of Acceptance and Commitment Therapy Self-Help for Carers of People With Multiple Sclerosis\\t\\tUNKNOWN\\tCarer Stress Syndrome\\tBEHAVIORAL: ACT Self-Help|BEHAVIORAL: ACT Self-Help with Telephone Support\\tUniversity of Nottingham\\t\\t24.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE\\t2016-12-01\\t2018-06\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT02912871\\tSubthalamotomy by ExAblate Transcranial System to Treat Motor Features of Parkinson\\'s Disease\\t\\tCOMPLETED\\tParkinson\\'s Disease\\tOTHER: MRIgHIFU unilateral subthalamotomy\\tFundación de investigación HM\\tInsightech\\t10.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\\t2016-04\\t2017-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03548571\\tDendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy\\tDEN-STEM\\tACTIVE_NOT_RECRUITING\\tGlioblastoma\\tBIOLOGICAL: Dendritic cell immunization|DRUG: Adjuvant temozolomide\\tOslo University Hospital\\t\\t60.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\\t2018-04-26\\t2025-05-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01449071\\tStudy Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)\\t\\tCOMPLETED\\tSystemic Lupus Erythematosus\\tBIOLOGICAL: Placebo|BIOLOGICAL: Epratuzumab 400 mg|BIOLOGICAL: Epratuzumab 1200 mg|BIOLOGICAL: Epratuzumab 100 mg|BIOLOGICAL: Epratuzumab 600 mg\\tUCB Pharma\\t\\t20.0\\tINDUSTRY\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT\", CARE_PROVIDER, INVESTIGATOR,\" OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2011-10\\t2013-03\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT03530371\\tIntranasal Dexmedetomidine for Sedated Hearing Testing\\t\\tCOMPLETED\\tAuditory Brainstem Response\\tDRUG: Dexmedetomidine Hydrochloride\\tFondation Lenval\\t\\t60.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC\\t2019-05-02\\t2021-12-31\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05921071\\tDo Patients Who Received Tranexamic Acid in Vaginal Hysterectomy Loose Les Blood\",\" Comparing to Patients Who Did Not?\\t\\tRECRUITING\\tVaginal Hysterectomy\\tDRUG: Tranexamic acid|DRUG: Placebo\\tWolfson Medical Center\\t\\t150.0\\tOTHER_GOV\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT\", CARE_PROVIDER,\" OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE\\t2023-01-22\\t2025-01-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04974671\\tTrial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma\\t\\tRECRUITING\\tRenal Cell Carcinoma|Metastatic Renal Cell Carcinoma|Oligoprogressive|Progression\\tRADIATION: Stereotactic Body Radiation Therapy\\tYale University\\t\\t30.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\\t2022-08-08\\t2027-04-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00080171\\tOsteoarthritis Initiative (OAI): A Knee Health Study\\t\\tCOMPLETED\\tOsteoarthritis|Knee Osteoarthritis\\t\\tNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)\\tGlaxoSmithKline|Merck Sharp & Dohme LLC|Novartis|Pfizer\\t4796.0\\tNIH\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2004-02\\t2015-10\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00368771\\tA Six-month Study to Compare Outcome Differences and Visceral Response ... Irritable Bowel Syndrome\\t\\tCOMPLETED\\tIrritable Bowel Syndrome\\tBEHAVIORAL: IBS Stress Management|BEHAVIORAL: IBS Symptom Management|BEHAVIORAL: IBS Educational Training\\tUniversity of California\",\" Los Angeles\\tNational Institute of Nursing Research (NINR)\\t163.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\\t2002-07\\t2010-05\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04979871\\tSARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19\\tDER-CoV2-001\\tCOMPLETED\\tVaccine Reaction\\tPROCEDURE: Venous bleeding\\tUniversity of Zurich\\t\\t50.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2021-07-22\\t2021-12-31\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04097171\\tThe Effect of Diet Composition on Performance\", Expenditure, Blood Lipids,\" and Appetite Hormones in Highly Trained Cyclists\\tDCAP\\tCOMPLETED\\tEndurance Cycling Performance\\tOTHER: Diet\\tTexas Christian University\\t\\t34.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE\\t2019-11-11\\t2020-03-30\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT06199271\\tNeoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma\\t\\tNOT_YET_RECRUITING\\tHead and Neck Squamous Cell Carcinoma\\tDRUG: Adebrelimab and dalpiciclib\\tZhongzheng Xiang\\t\\t30.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\\t2024-01-31\\t2026-12-31\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04032171\\tStudy of Evobrutinib in Participants With RMS\\t\\tTERMINATED\\tRelapsing-remitting Multiple Sclerosis\\tDRUG: Evobrutinib|DRUG: Avonex®|DRUG: Avonex® matched Placebo|DRUG: Evobrutinib matched Placebo\\tEMD Serono Research & Development Institute\",\" Inc.\\tMerck KGaA\", Darmstadt,\" Germany\\t1.0\\tINDUSTRY\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT\", CARE_PROVIDER, INVESTIGATOR,\" OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2019-09-10\\t2020-05-20\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05674071\\tApplying an Osteopathic Intervention to Improve Mental Health Symptoms: a Mixed-methods Feasibility Study Protocol.\\t\\tCOMPLETED\\tMental Health Issue\\tBEHAVIORAL: Articulation/HVT|BEHAVIORAL: Soft-tissue massage|BEHAVIORAL: Craniosacral techniques|BEHAVIORAL: Combination of the three interventions: HVT\",\" soft-tissue and craniosacral techniques\\tSwansea University\\tOsteopathic Foundation|University College of Osteopathy\\t32.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2022-12-20\\t2023-08-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT00858871\\tFirst Line Hepato Cellular Carcinoma (HCC)\\tBRISK FL\\tCOMPLETED\\tHepato Cellular Carcinoma (HCC)\\tDRUG: Brivanib|DRUG: Placebo|DRUG: Sorafenib|DRUG: Placebo\\tBristol-Myers Squibb\\t\\t1714.0\\tINDUSTRY\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT\", CARE_PROVIDER, INVESTIGATOR,\" OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2009-05\\t2013-09\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01776671\\tOnce Daily Gabapentin in the Treatment of Post Amputation Pain\\t\\tUNKNOWN\\tPain|Quality of Life\\tDRUG: Gralise\\tChicago Anesthesia Pain Specialists\\t\\t16.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\\t2013-02\\t2018-12\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01363271\\tCost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients\\t\\tCOMPLETED\\tComplicated Skin and Structure Infection|Nosocomial Pneumonia\\tDRUG: Linezolid|DRUG: Vancomycin|DRUG: Linezolid|DRUG: Vancomycin\\tPfizer\\tUniversity of Maryland|Lodise & Lodise\",\" LLC\\t7260.0\\tINDUSTRY\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2011-05\\t2012-05\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT01282671\\tEffects of Deep Breathing Exercises Two Months After Cardiac Surgery\\t\\tCOMPLETED\\tCABG|Valve Surgery\\tOTHER: Breathing exercises\\tUppsala University\\tThe Swedish Research Council|Örebro County Council\\t357.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2007-09\\t2012-08\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05683171\\tA Phase 1/2\",\" Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma\\t\\tRECRUITING\\tLymphoma\\tDRUG: Rituximab|DRUG: Lenalidomide|DRUG: Valemetostat\\tM.D. Anderson Cancer Center\\tDaiichi Sankyo\\t60.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\\t2023-05-19\\t2027-09-30\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT05334771\\tEarly Detection of Endolymphatic Hydrops in Hypothyroid Patients\\t\\tNOT_YET_RECRUITING\\tHypothyroidism\\tDEVICE: Dual band pure tune audiometer\\tAssiut University\\t\\t50.0\\tOTHER\\tOBSERVATIONAL\\tObservational Model: |Time Perspective: p\\t2022-09\\t2025-04\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\\r\\n\"NCT04718571\\tAn Ecological Analysis of Nontuberculous Mycobacteria in the Geneva Area (2015-2020)\\t\\tCOMPLETED\\tEcology of Nontubercuous Mycobacteria|Geneva Area\\t\\tUniversity Hospital\",\" Geneva\\t\\t231.0\\tOTHER\\tOBSERVATI'"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dbutils.fs.head(\"/FileStore/tables/\" + fileroot + \".csv\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "f11f1c25-1336-4106-81cc-d496e40bcac3",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "# CREATE RDD FOR CLINICAL TRIALS\n",
    "\n",
    "# defines a function to read and convert the clinicaltrial data into RDD"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "c14dc0e8-95ce-4fff-a90d-4741db469a89",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [],
   "source": [
    "def load_clinical_trial_data(clinicaltrial_2023):\n",
    "    \"\"\"\n",
    "    Load clinical trial data from a CSV file into an RDD.\n",
    "\n",
    "    Parameters:\n",
    "        clinicaltrial_2023 (str): The name of the CSV file to load.\n",
    "\n",
    "    Returns:\n",
    "        pyspark.rdd.RDD: An RDD containing the clinical trial data.\n",
    "    \"\"\"\n",
    "    crdd = sc.textFile(\"/FileStore/tables/\" + clinicaltrial_2023 + \".csv\")\n",
    "    return crdd"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "c743ad21-355d-47b9-a2d8-72e26d9a5805",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "# CREATE RDD FOR pharmaceutical data\n",
    "\n",
    "# defines a function to read and convert the pharmaceutical data into RDD"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "5bf64a0f-fc14-4916-b36c-bd1b39c41e0e",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [],
   "source": [
    "def load_pharma_data(pharma):\n",
    "    \"\"\"\n",
    "    Load pharmaceutical data from a CSV file into an RDD.\n",
    "\n",
    "    Parameters:\n",
    "        pharma (str): The name of the pharmaceutical data CSV file.\n",
    "\n",
    "    Returns:\n",
    "        pyspark.rdd.RDD: An RDD containing the pharmaceutical data.\n",
    "    \"\"\"\n",
    "    prdd = sc.textFile(\"/FileStore/tables/\" + pharma + \".csv\")\n",
    "    return prdd"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "95af44c7-9827-4cd4-9539-4df0f888b6bc",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "# Removing the delimeters\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "f32a14ff-7fd5-489b-a6cf-3f82633f1996",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [],
   "source": [
    "delimiter_selector = {\n",
    "    \"clinicaltrial_2023\": \"\\t\",\n",
    "    \"clinicaltrial_2021\": \"|\",\n",
    "    \"clinicaltrial_2020\": \"|\",\n",
    "    \"pharma\": \",\"\n",
    "}\n",
    "\n",
    "def clean_clinical_rdd(crdd, clinicaltrial_2023):\n",
    "    \"\"\"\n",
    "    Clean the clinical trial RDD by splitting each line using the delimiter\n",
    "    specified by the file type and removing unwanted characters.\n",
    "\n",
    "    Parameters:\n",
    "        crdd (pyspark.rdd.RDD): The RDD containing clinical trial data.\n",
    "        clinicaltrial_2023 (str): The name of the clinical trial file.\n",
    "\n",
    "    Returns:\n",
    "        pyspark.rdd.RDD: The cleaned RDD.\n",
    "    \"\"\"\n",
    "    CLEAN_CRDD = crdd.map(lambda x: x.split(delimiter_selector[clinicaltrial_2023])).map(lambda x: [i.replace(\",\",'').replace('\"','')for i in x])\n",
    "    return CLEAN_CRDD\n",
    "\n",
    "def clean_pharma_rdd(prdd, pharma):\n",
    "    \"\"\"\n",
    "    Clean the pharmaceutical RDD by splitting each line using the delimiter\n",
    "    specified by the file type and removing unwanted characters.\n",
    "\n",
    "    Parameters:\n",
    "        prdd (pyspark.rdd.RDD): The RDD containing pharmaceutical data.\n",
    "        pharma_file (str): The name of the pharmaceutical file.\n",
    "\n",
    "    Returns:\n",
    "        pyspark.rdd.RDD: The cleaned RDD.\n",
    "    \"\"\"\n",
    "    CLEAN_PRDD = prdd.map(lambda x: x.split(delimiter_selector[pharma])).map(lambda x: [i.replace(\",\",'').replace('\"','')for i in x])\n",
    "    return CLEAN_PRDD"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "eee266d5-8fef-4845-8819-5ff733bda47b",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "# Creating new RDD  after cleaning the data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "5839b2ab-0ad2-47fa-b0ac-2067ea406455",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "execute_result",
     "data": {
      "text/plain": [
       "[['Id',\n",
       "  'Study Title',\n",
       "  'Acronym',\n",
       "  'Status',\n",
       "  'Conditions',\n",
       "  'Interventions',\n",
       "  'Sponsor',\n",
       "  'Collaborators',\n",
       "  'Enrollment',\n",
       "  'Funder Type',\n",
       "  'Type',\n",
       "  'Study Design',\n",
       "  'Start',\n",
       "  'Completion'],\n",
       " ['NCT03630471',\n",
       "  'Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India',\n",
       "  'PRIDE',\n",
       "  'COMPLETED',\n",
       "  'Mental Health Issue (E.G. Depression Psychosis Personality Disorder Substance Abuse)',\n",
       "  \"BEHAVIORAL: PRIDE 'Step 1' problem-solving intervention|BEHAVIORAL: Enhanced usual care\",\n",
       "  'Sangath',\n",
       "  'Harvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine',\n",
       "  '250.0',\n",
       "  'OTHER',\n",
       "  'INTERVENTIONAL',\n",
       "  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT',\n",
       "  '2018-08-20',\n",
       "  '2019-02-28'],\n",
       " ['NCT05992571',\n",
       "  'Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity',\n",
       "  '',\n",
       "  'RECRUITING',\n",
       "  'Cerebrovascular Function|Cognition',\n",
       "  'OTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB',\n",
       "  'McMaster University',\n",
       "  \"Alzheimer's Society of Brant Haldimand Norfolk Hamilton Halton\",\n",
       "  '30.0',\n",
       "  'OTHER',\n",
       "  'INTERVENTIONAL',\n",
       "  'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE',\n",
       "  '2023-10-25',\n",
       "  '2024-08'],\n",
       " ['NCT00237471',\n",
       "  'Impact of Tight Glycaemic Control in Acute Myocardial Infarction',\n",
       "  '',\n",
       "  'TERMINATED',\n",
       "  'Myocardial Infarct|Hyperglycemia',\n",
       "  'DRUG: Insulin (tight blood glucose control)',\n",
       "  'Melbourne Health',\n",
       "  'National Health and Medical Research Council Australia|Bristol-Myers Squibb',\n",
       "  '40.0',\n",
       "  'OTHER',\n",
       "  'INTERVENTIONAL',\n",
       "  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT',\n",
       "  '2005-10',\n",
       "  '2006-05'],\n",
       " ['NCT03820271',\n",
       "  'New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation',\n",
       "  'SUPERMELD',\n",
       "  'RECRUITING',\n",
       "  'Decompensated Cirrhosis|Liver Transplantation',\n",
       "  'OTHER: SuperMELD',\n",
       "  'Assistance Publique - Hôpitaux de Paris',\n",
       "  '',\n",
       "  '500.0',\n",
       "  'OTHER',\n",
       "  'INTERVENTIONAL',\n",
       "  'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER',\n",
       "  '2020-10-01',\n",
       "  '2023-10-01']]"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Creating new RDD  after cleaning the data\n",
    "\n",
    "# Creating the new RDD\n",
    "Clinical_RDD = load_clinical_trial_data(fileroot)\n",
    "PHARMA_RDD = load_pharma_data(pharma)\n",
    "\n",
    "# Cleaning the RDD\n",
    "Clinical_RDD_Clean = clean_clinical_rdd(Clinical_RDD, fileroot)\n",
    "PHARMA_RDD_Clean = clean_pharma_rdd(PHARMA_RDD, pharma)\n",
    "\n",
    "# Take first 5 elements from cleaned Clinical RDD\n",
    "Clinical_RDD_Clean.take(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "0a2470a9-6cb7-41a3-a93e-56c4abcb743a",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "# PROBLEM ANSWERS"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "e51b054d-526e-4bb6-b031-e5173279be79",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of studies in the dataset: 483422\n"
     ]
    }
   ],
   "source": [
    "# QUESTION 1: NUMBER OF STUDIES IN THE DATASET\n",
    "\n",
    "header = Clinical_RDD.first()\n",
    "\n",
    "# Extract study names and count distinct studies\n",
    "num_studies = (\n",
    "    Clinical_RDD\n",
    "    .filter(lambda row: row != header)      \n",
    "    .distinct()                   \n",
    "    .count()                      \n",
    ")\n",
    "\n",
    "print(\"Number of studies in the dataset:\", num_studies)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "844d41bb-1c38-4d92-aabe-90284014c7c9",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of distinct rows (excluding header): 483422\n"
     ]
    }
   ],
   "source": [
    "# Using user defined functionto find the distinct count\n",
    "from pyspark.sql import Row\n",
    "\n",
    "def count_distinct_rows(rdd, header_row):\n",
    "    # Define a function to check if a row is equal to the header\n",
    "    def is_not_header(row):\n",
    "        return row != header_row\n",
    "\n",
    "    # Filter out the header and count the distinct rows\n",
    "    distinct_count = rdd.filter(is_not_header).distinct().count()\n",
    "\n",
    "    return distinct_count\n",
    "\n",
    "# Assuming Clinical_RDD is your RDD and header is the first row\n",
    "header = Clinical_RDD.first()\n",
    "\n",
    "# Convert the header to a Row object for compatibility\n",
    "header_row = Row(*header)\n",
    "\n",
    "# Get the distinct count of rows\n",
    "distinct_count = count_distinct_rows(Clinical_RDD, header_row)\n",
    "\n",
    "# Print the distinct count\n",
    "print(\"Number of distinct rows (excluding header):\", distinct_count - 1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "6e602f0d-4ddb-4c9c-b11b-2ca48eb45dbb",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "execute_result",
     "data": {
      "text/plain": [
       "[('INTERVENTIONAL', 371382),\n",
       " ('OBSERVATIONAL', 110221),\n",
       " ('EXPANDED_ACCESS', 928)]"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# QUESTION TWO: ALL TYPES OF TRIALS & THEIR FREQUENCY\n",
    "\n",
    "type_of_trial = Clinical_RDD_Clean.first().index('Type')\n",
    "Clinical_RDD_Clean.filter(lambda x: len(x) > type_of_trial + 1).map(lambda x: (x[type_of_trial], 1)).filter(lambda row: row[0] != 'Type').reduceByKey(lambda a,b: a + b).filter(lambda x: x[0] != '').sortBy(lambda x: x[1], ascending=False).collect()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "04fab411-f98b-473a-b941-a9b892a7dd66",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "execute_result",
     "data": {
      "text/plain": [
       "[('Healthy', 7997),\n",
       " ('Breast Cancer', 4556),\n",
       " ('Prostate Cancer', 2650),\n",
       " ('Asthma', 2309),\n",
       " ('Obesity', 2284)]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# QUESTION 3: TOP 5 CONDITIONS WITH THEIR FREQUENCIES\n",
    "\n",
    "conditions_delimeter = {\n",
    "    \"clinicaltrial_2023\": \"\\t\",\n",
    "    \"clinicaltrial_2021\": \",\",\n",
    "    \"clinicaltrial_2020\": \",\",\n",
    "}\n",
    "conditions_column_index = Clinical_RDD_Clean.first().index('Conditions')\n",
    "\n",
    "Clinical_RDD_Clean.flatMap(lambda x: x[conditions_column_index].split(conditions_delimeter[fileroot])).filter(lambda row: row != 'Conditions').filter(lambda row: row != '').map(lambda x: (x, 1)).reduceByKey(lambda a,b: a + b).sortBy(lambda x: x[1], ascending=False).take(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "ef071759-c695-447b-8144-09cacbf30ac4",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "execute_result",
     "data": {
      "text/plain": [
       "[('National Cancer Institute (NCI)', 3410),\n",
       " ('Assiut University', 3335),\n",
       " ('Cairo University', 3023),\n",
       " ('Assistance Publique - Hôpitaux de Paris', 2951),\n",
       " ('Mayo Clinic', 2766),\n",
       " ('M.D. Anderson Cancer Center', 2702),\n",
       " ('Novartis Pharmaceuticals', 2393),\n",
       " ('National Institute of Allergy and Infectious Diseases (NIAID)', 2340),\n",
       " ('Massachusetts General Hospital', 2263),\n",
       " ('National Taiwan University Hospital', 2181)]"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# QUESTION 4,  TOP 10 NON - PHARMA COMPANIES\n",
    "\n",
    "clinical_trial_sponsor_col_index = Clinical_RDD_Clean.first().index('Sponsor')\n",
    "\n",
    "parent_pharm_comp = PHARMA_RDD_Clean.map(lambda x: x[1].replace('\"', ''))\n",
    "\n",
    "Clinical_RDD_Clean.map(lambda x: x[clinical_trial_sponsor_col_index]).filter(lambda row: row != 'Sponsor').subtract(PHARMA_RDD_Clean.map(lambda x: x[1].replace('\"', ''))).map(lambda x: (x, 1)).reduceByKey(lambda x, y: x + y).sortBy(lambda x: x[1], ascending=False).take(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "af942d07-ec71-401b-862c-b7e48ae59ad1",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(Jan, 1494)\n(Feb, 1272)\n(Mar, 1552)\n(Apr, 1324)\n(May, 1415)\n(Jun, 1619)\n(Jul, 1360)\n(Aug, 1230)\n(Sept, 1152)\n(Oct, 1058)\n(Nov, 909)\n(Dec, 1082)\n"
     ]
    }
   ],
   "source": [
    "# QUESTION 5 The completed trial for 2023\n",
    "# Assuming month_selector, ct_completion_col_index, ct_status_col_index, year, and CLINICAL_RDD_Clean are defined\n",
    "year = {\n",
    "    \"clinicaltrial_2020\": \"2020\",\n",
    "    \"clinicaltrial_2021\": \"2021\",\n",
    "    \"clinicaltrial_2023\": \"2023\",\n",
    "}\n",
    "Clinical_RDD_Clean = Clinical_RDD_Clean.map(lambda x: [i.replace(',', '').replace('\"', '') for i in x])\n",
    "\n",
    "# Define a dictionary to map month abbreviations to their corresponding full names\n",
    "month_selector = {\"01\": \"Jan\", \"02\":\"Feb\", \"03\":\"Mar\", \"04\":\"Apr\", \"05\":\"May\", \"06\":\"Jun\", \"07\":\"Jul\", \"08\":\"Aug\", \"09\":\"Sept\", \"10\":\"Oct\", \"11\":\"Nov\", \"12\":\"Dec\"}\n",
    "\n",
    "# Convert month abbreviations to their corresponding numerical representations\n",
    "month_numerical = {month: int(num) for num, month in month_selector.items()}\n",
    "\n",
    "ct_completion_col_index = Clinical_RDD_Clean.first().index('Completion')\n",
    "ct_status_col_index = Clinical_RDD_Clean.first().index('Status')\n",
    "\n",
    "# Filter and process the data to find completed studies in 2023\n",
    "completed_studies = Clinical_RDD_Clean \\\n",
    "    .filter(lambda x: len(x) > ct_completion_col_index and len(x) > ct_status_col_index) \\\n",
    "    .map(lambda x: (x[ct_completion_col_index], x[ct_status_col_index])) \\\n",
    "    .filter(lambda x: x[0] != 'Completion' and (x[1] == 'COMPLETED' or x[1] == 'Completed')) \\\n",
    "    .map(lambda x: (x[0][5:7], x[0][0:4])) \\\n",
    "    .filter(lambda x: x[1] == year[\"clinicaltrial_2023\"]) \\\n",
    "    .map(lambda x: (month_selector[x[0]], 1)) \\\n",
    "    .reduceByKey(lambda a, b: a + b) \\\n",
    "    .sortBy(lambda x: month_numerical[x[0]])\n",
    "\n",
    "# Convert RDD to the specified format\n",
    "result = completed_studies.collect()\n",
    "\n",
    "for month, count in result:\n",
    "    print(f'({month}, {count})')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "6283b0dd-af1f-45d8-a529-d428fa986581",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "display_data",
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Assuming completed_studies is the RDD containing the result\n",
    "data = completed_studies.collect()  # Collect the data from RDD\n",
    "\n",
    "# Separate months and counts from the collected data\n",
    "months = [item[0] for item in data]\n",
    "counts = [item[1] for item in data]\n",
    "\n",
    "# Create a line chart\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.plot(months, counts, marker='o', linestyle='-')\n",
    "\n",
    "# Add data points on the line\n",
    "for x, y in zip(months, counts):\n",
    "    plt.text(x, y, f'{y}', ha='right', va='bottom', fontsize=10)\n",
    "\n",
    "# Add title and labels\n",
    "plt.title('Number of Completed Studies Over Time (2023)')\n",
    "plt.xlabel('Month')\n",
    "plt.ylabel('Number of Completed Studies')\n",
    "\n",
    "# Rotate x-axis labels for better readability\n",
    "plt.xticks(rotation=45)\n",
    "\n",
    "# Show plot\n",
    "plt.tight_layout()\n",
    "plt.grid(True)  # Add grid for better visualization\n",
    "plt.show()\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "6e256e9d-26ba-4937-9fc7-fec9b4126ee2",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "execute_result",
     "data": {
      "text/plain": [
       "[('COMPLETED', 263498),\n",
       " ('RECRUITING', 66158),\n",
       " ('UNKNOWN', 64813),\n",
       " ('TERMINATED', 28022),\n",
       " ('NOT_YET_RECRUITING', 20098)]"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# FURTHER ANALYSIS 6\n",
    "# TOP 5 CLINICAL TRIAL STATUS WITH THEIR FREQUENCIES\n",
    "\n",
    "Status_delimeter = {\n",
    "    \"clinicaltrial_2023\": \"\\t\",\n",
    "    \"clinicaltrial_2021\": \",\",\n",
    "    \"clinicaltrial_2020\": \",\",\n",
    "}\n",
    "Status_column_index = Clinical_RDD_Clean.first().index('Status')\n",
    "\n",
    "Clinical_RDD_Clean.flatMap(lambda x: x[Status_column_index].split(Status_delimeter[fileroot])).filter(lambda row: row != 'Status').filter(lambda row: row != '').map(lambda x: (x, 1)).reduceByKey(lambda a,b: a + b).sortBy(lambda x: x[1], ascending=False).take(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "d43741d5-3328-4b41-ad18-249a9fe7809a",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "display_data",
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Define the delimiter for the Status column based on the clinical trial data\n",
    "status_delimiter = {\n",
    "    \"clinicaltrial_2023\": \"\\t\",\n",
    "    \"clinicaltrial_2021\": \",\",\n",
    "    \"clinicaltrial_2020\": \",\",\n",
    "}\n",
    "\n",
    "# Extract status data based on the specified clinical trial year\n",
    "status_column_index = Clinical_RDD_Clean.first().index('Status')\n",
    "status_rdd = Clinical_RDD_Clean.flatMap(lambda x: x[status_column_index].split(status_delimiter[fileroot])) \\\n",
    "                              .filter(lambda row: row != 'Status') \\\n",
    "                              .filter(lambda row: row != '') \\\n",
    "                              .map(lambda x: (x, 1)) \\\n",
    "                              .reduceByKey(lambda a, b: a + b) \\\n",
    "                              .sortBy(lambda x: x[1], ascending=False)\n",
    "\n",
    "# Get the top 5 statuses with their frequencies\n",
    "top_statuses = status_rdd.take(5)\n",
    "\n",
    "# Extract status and frequency data\n",
    "statuses = [status[0] for status in top_statuses]\n",
    "frequencies = [status[1] for status in top_statuses]\n",
    "\n",
    "# Create a bar chart\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.bar(statuses, frequencies, color='skyblue')\n",
    "\n",
    "# Add labels and title\n",
    "plt.xlabel('Status')\n",
    "plt.ylabel('Frequency')\n",
    "plt.title('Top 5 Statuses with Their Frequencies')\n",
    "\n",
    "# Rotate x-axis labels for better readability if needed\n",
    "plt.xticks(rotation=45)\n",
    "\n",
    "# Show the plot\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "500d2fc6-bb80-4d62-8333-813d66cd0fb2",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "application/vnd.databricks.v1+notebook": {
   "dashboards": [],
   "language": "python",
   "notebookMetadata": {
    "mostRecentlyExecutedCommandWithImplicitDF": {
     "commandId": 2280407177436250,
     "dataframes": [
      "_sqldf"
     ]
    },
    "pythonIndentUnit": 4
   },
   "notebookName": "Oluwadamilola_Kolawole_rdd",
   "widgets": {}
  }
 },
 "nbformat": 4,
 "nbformat_minor": 0
}
